CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

VERO is no longer listed: the SEC shows no trading symbol for it and it has no recent price, usually after an acquisition. CatalystAlert no longer tracks its catalysts.

Venus Concept Inc.

VERO
$563KMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for VERO. That does not mean none is planned.

Get an email about VERO's next catalysts

Track Venus Concept (VERO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How VERO's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQSurgical & Medical Instruments & ApparatusπŸ‡ΊπŸ‡ΈNorth AmericaTORONTO
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Venus Concept Inc.'s drug pipeline?β†’

CatalystAlert tracks 1 drug candidate in Venus Concept Inc.'s (VERO) pipeline across Phase 3. Its lead program is CSE-1034 (Ceftriaxone + Sulbactam + EDTA) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Venus Concept Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Venus Concept Inc. (VERO) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track VERO biotech catalysts?β†’

Add VERO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Venus Concept Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply